Takayama, K., Ichiki, M., Tokunaga, S., Inoue, K., Kawasaki, M., Uchino, J., & Nakanishi, Y. (2019). Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer. Oncologist.
Citação norma ChicagoTakayama, Koichi, Masao Ichiki, Shoji Tokunaga, Koji Inoue, Masayuki Kawasaki, Junji Uchino, and Yoichi Nakanishi. "Randomized Phase II Study of Weekly Paclitaxel Plus Carboplatin Versus Biweekly Paclitaxel Plus Carboplatin for Patients With Previously Untreated Advanced Non‐Small Cell Lung Cancer." Oncologist 2019.
Citação norma MLATakayama, Koichi, et al. "Randomized Phase II Study of Weekly Paclitaxel Plus Carboplatin Versus Biweekly Paclitaxel Plus Carboplatin for Patients With Previously Untreated Advanced Non‐Small Cell Lung Cancer." Oncologist 2019.